| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1047 | 2019 |
| Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures JS Bajaj, JG O'Leary, KR Reddy, F Wong, SW Biggins, H Patton, ... Hepatology 60 (1), 250-256, 2014 | 531 | 2014 |
| Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis PY Kwo, F Poordad, A Asatryan, S Wang, DL Wyles, T Hassanein, ... Journal of hepatology 67 (2), 263-271, 2017 | 344 | 2017 |
| New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection F Wong, JG O'Leary, KR Reddy, H Patton, PS Kamath, MB Fallon, ... Gastroenterology 145 (6), 1280-1288. e1, 2013 | 274 | 2013 |
| NACSELD acute‐on‐chronic liver failure (NACSELD‐ACLF) score predicts 30‐day survival in hospitalized patients with cirrhosis JG O'leary, KR Reddy, G Garcia‐Tsao, SW Biggins, F Wong, MB Fallon, ... Hepatology 67 (6), 2367-2374, 2018 | 240 | 2018 |
| The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis JS Bajaj, KR Reddy, P Tandon, F Wong, PS Kamath, G Garcia‐Tsao, ... Hepatology 64 (1), 200-208, 2016 | 220 | 2016 |
| Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: a partially randomized phase 3 clinical trial D Wyles, F Poordad, S Wang, L Alric, F Felizarta, PY Kwo, B Maliakkal, ... Hepatology 67 (2), 514-523, 2018 | 175 | 2018 |
| Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non … RJ Vickers, GS Tillotson, R Nathan, S Hazan, J Pullman, C Lucasti, ... The Lancet infectious diseases 17 (7), 735-744, 2017 | 140 | 2017 |
| Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures JS Bajaj, JG O’Leary, P Tandon, F Wong, G Garcia-Tsao, PS Kamath, ... Clinical Gastroenterology and Hepatology 15 (4), 565-574. e4, 2017 | 133 | 2017 |
| High efficacy of ABT-493 and ABT-530 treatment in patients with HCV genotype 1 or 3 infection and compensated cirrhosis E Gane, F Poordad, S Wang, A Asatryan, PY Kwo, J Lalezari, DL Wyles, ... Gastroenterology 151 (4), 651-659. e1, 2016 | 126 | 2016 |
| Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET SC Gordon, AJ Muir, JK Lim, B Pearlman, CK Argo, A Ramani, ... Journal of hepatology 62 (2), 286-293, 2015 | 119 | 2015 |
| Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience MZ Molnar, S Nair, O Cseprekal, M Yazawa, M Talwar, V Balaraman, ... American Journal of Transplantation 19 (11), 3046-3057, 2019 | 116 | 2019 |
| North American Consortium For The Study Of End-Stage Liver Disease (NACSELD). Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures JS Bajaj, JG O’Leary, KR Reddy, F Wong, SW Biggins, H Patton, ... Hepatology 60 (1), 250-256, 2014 | 102 | 2014 |
| Bouveret's syndrome complicated by distal gallstone ileus after laser lithotropsy using Holmium: YAG laser MM Alsolaiman, C Reitz, AT Nawras, JB Rodgers, BJ Maliakkal BMC gastroenterology 2, 1-4, 2002 | 101 | 2002 |
| Prediction of fungal infection development and their impact on survival using the NACSELD cohort JS Bajaj, RK Reddy, P Tandon, F Wong, PS Kamath, SW Biggins, ... Official journal of the American College of Gastroenterology| ACG 113 (4 …, 2018 | 99 | 2018 |
| Safety, Anti-viral Efficacy and Pharmacokinetics (pk) of Sofosbuvir (sof) in Patients with Severe Renal Impairment: 966 EJ Gane, RA Robson, M Bonacini, B Maliakkal, L Liu, K Sajwani, ... Hepatology 60, 667A, 2014 | 98 | 2014 |
| Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis A Bozorgzadeh, M Orloff, P Abt, G Tsoulfas, D Younan, R Kashyap, A Jain, ... Liver Transplantation 13 (6), 807-813, 2007 | 95 | 2007 |
| A Karnofsky performance status–based score predicts death after hospital discharge in patients with cirrhosis P Tandon, KR Reddy, JG O'Leary, G Garcia‐Tsao, JG Abraldes, F Wong, ... Hepatology 65 (1), 217-224, 2017 | 86 | 2017 |
| Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases—an analysis of the UNOS database R Kashyap, S Safadjou, R Chen, P Mantry, R Sharma, V Patil, M Maloo, ... Journal of Gastrointestinal Surgery 14 (9), 1362-1369, 2010 | 84 | 2010 |
| Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes F Wong, JG O'leary, KR Reddy, G Garcia-Tsao, MB Fallon, SW Biggins, ... Official journal of the American College of Gastroenterology| ACG 112 (7 …, 2017 | 77 | 2017 |
